Catherine Slegers
About Catherine Slegers
Catherine Slegers is the Director of Global Regulatory Sciences Liaison and Strategy for Europe Oncology at Bristol-Myers Squibb, with extensive experience in regulatory affairs within the pharmaceutical industry, particularly in oncology.
Title
Catherine Slegers currently holds the position of Director, Global Regulatory Sciences Liaison and Strategy - Europe Oncology at Bristol-Myers Squibb. She also serves as Director, Regulatory Affairs Europe at Merck in Brussels, Belgium.
Education and Expertise
Catherine Slegers has an extensive academic background, having studied at Université Catholique de Louvain. She completed a Doctor of Philosophy and a Doctor of Pharmacy, with her doctoral studies spanning from 1999 to 2005. She also attended Université Catholique de Louvain from 1994 to 1999 for her earlier education. Additionally, she studied at Jakarta Intercultural School for one year and International School of Kuala Lumpur for another year.
Professional Background
Catherine Slegers has a robust professional background in the pharmaceutical industry. At Merck, she has served in various roles, including Director and Associate Director of Regulatory Affairs Europe. She was responsible for overseeing regulatory strategies and ensuring regulatory compliance across the European region. Her tenure at Merck spans from 2012 to the present.
Experience at GSK
Catherine Slegers has a comprehensive experience at GSK. She worked as World Wide Vaccine Registration Manager and in Technical Regulatory Affairs within Global Vaccine Development. Additionally, she served in Clinical Scientific Writing in Global Clinical Research and Development. Her overall contributions at GSK spanned several roles focused on the development and regulatory approval of vaccines.
Role at Université Catholique de Louvain
Catherine Slegers served as a Teaching and Research Assistant at Université Catholique de Louvain from 1999 to 2005. Her work involved the laboratory of physico-chemical and chemical analysis of drugs. This position offered her an opportunity to contribute to academic research and teaching in the field of pharmaceutical sciences.